Pharmocogenetics in the future treatment of rheumatology
نویسندگان
چکیده
Henk-Jan Guchelaar†, Judith AM Wessels & Tom WJ Huizinga †Author for correspondence Leiden University Medical Center, Department of Clinical Pharmacy & Toxicology, PO Box 9600, NL 2300 RC Leiden, The Netherlands Tel.: +31 71 526 2790; Fax: +31 71 524 8101; [email protected] ‘Pharmacogenetics ... holds the promise not only to explain interindividual variability in drug response, but also to predict efficacy and adverse drug events in individual patients.’
منابع مشابه
Reparative radiological changes of hip joint after TNF inhibitors in ankylosing spondylitis
Background: Hip involvement in ankylosing spondylitis (AS) is a common extraspinal arthritic manifestation, which is associated to a worse functional outcome. Little data are available on the effectiveness of conservative treatment strategies. The TNF inhibitors have been proven effective on AS activity parameters. Their structural effect on hip disease however, little is studied. Case pres...
متن کاملCoincidence of Sarcoidosis With Ankylosing Spondylitis in a 48-Year-Old Woman; A Therapeutic Challenge
Introduction: A case of pulmonary sarcoidosis is reported because of difficulties in diagnosis and treatment, including the co-existence of ankylosing spondylitis (AS) and severe corticosteroid dependence. Case Presentation: A 48-year-old nonsmoking woman referred to the hospital because of chronic nonproductive cough and dyspnea with a 10-year history of...
متن کاملHow Much Improvement is Expected in Ocular Lesions of Behçet's Disease Treated with Pulse Cyclophosphamide?
Background: The natural history of ocular lesions in Behçet's disease is toward severe loss of vision/blindness in few years, whereas cytotoxic drugs have changed the outcome. Several open labeled cohort studies showed pulse cyclophosphamide (PCP) to be the best choice. Since one third of these patients are resistant to PCP it is important to know how much improvement one can expect from the r...
متن کاملDifferentiation-Inducing Activity of the Phyto-polyphenols Epigallocatechin-3-gallate and Kaempferol on NB4 Cells
Background and Objective: The rate of survival in acute promyelocytic leukemia (APL) can dramatically improve, if the patients receive all-trans-retinoic acid (ATRA) treatment. However, this drugchr('39')s toxicity is a major problem in APL treatment. Previous researches have demonstrated that phyto-polyphenols such as epigallocatechin gallate (EGCG) and kaempferol cause apoptosis in hematopoie...
متن کامل